As far back as the introduction of the HMO, the US health care system has been trying to find ways to incentivize high-value care and discourage low-value care. In this breakfast briefing, Bloomberg convenes health care sector CEOs, government, and thought leaders to discuss how escalating health care costs and the growing financial burden facing many patients are demanding greater acceleration of the move toward a value-driven health care system.
September 19 - Tuesday
Sponsor Spotlight: 5 Questions With...
Stephen J. Ubl
President & CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)
Registration and Networking Breakfast
Collaborating on High-Value Care and Treatment
CEOs discuss the case for clearing the path toward a value-driven health care system, including evolving current infrastructure to support it. How can players across the health care system interact and change how care and treatment are paid for with a focus on rewarding what works for patients, and what technology, methods, regulations, and metrics are needed to capture and analyze information that will keep the movement toward value-driven care moving forward.
Co-anchor, "Bloomberg Markets Americas" & "Bloomberg Surveillance", Bloomberg
Delos M. Cosgrove
Chief Executive Officer & President, Cleveland Clinic
Executive Vice Chairman & Chief Executive Officer, Walgreens Boots Alliance
Ian C. Read
Chairman of the Board & Chief Executive Officer, Pfizer
Gary M. Reedy Gary M. Reedy
Chief Executive Officer, American Cancer Society, Inc.
How it works
Executives from a pharmaceutical company and a health care payer company, that are currently partnering on a value-based contract, share insights on how care and treatment are paid for with a focus on rewarding what works for patients. This discussion will focus on how these companies are innovating away from the traditional volume-based payment model to improve outcomes for patients, manage costs, and invest in better treatments for the future.
Health Care Reporter, Bloomberg
Policy changes will continue to challenge the way the health care industry operates. In this fireside chat, we will explore how the system can insure that it continues to move towards value and is not held back while adjusting to these changes, and look to define what can be done to increase dynamism and drive progress in healthcare through partnerships, pilot programs, and funding initiatives.
Health Regulation Reporter, Bloomberg
Mark McClellanDuke-Margolis Center for Health Policy at Duke University Robert J. Margolis Professor of Business, Medicine, and Policy & Director
Amy AbernethyFlatiron Health Chief Medical Officer, Chief Scientific Officer & Senior Vice President, Oncology
Anna EdneyBloomberg Health Regulation Reporter
Harold L. PazAetna Executive Vice President and Chief Medical Officer
Joaquin DuatoJohnson & Johnson Executive Vice President and Chairman, Pharmaceuticals
Drew ArmstrongBloomberg Health Care Reporter
Gary M. Reedy Gary M. ReedyAmerican Cancer Society, Inc. Chief Executive Officer
Ian C. ReadPfizer Chairman of the Board & Chief Executive Officer
Stefano PessinaWalgreens Boots Alliance Executive Vice Chairman & Chief Executive Officer
David GuraBloomberg Co-anchor, "Bloomberg Markets Americas" & "Bloomberg Surveillance"
Stephen J. UblPharmaceutical Research and Manufacturers of America (PhRMA) President & CEO
Delos M. CosgroveCleveland Clinic Chief Executive Officer & President
Biopharmaceutical innovation is advancing faster than ever before, and we need to make sure we have a payment and reimbursement system that is as innovative as the medicines. That is why the biopharmaceutical industry launched The Value Collaborative to bring researchers, caregivers, patients, payers and policymakers together to advance solutions that will enable the private sector to lead the move toward a value driven health care system.